Sign in

NCT04724941Recruiting

Prodromal Alpha-Synuclein Screening in Parkinson's Disease Study

Source: ClinicalTrials.gov · Last updated 22 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The PASS-PD study is set out to screen individuals from the general population with an increased risk for the development of Parkinson's Disease (PD) and to investigate this highly enriched cohort longitudinally for five year. A special focus is placed on implementation of ethical standards for early risk disclosure in PD.

Status (registry)
Recruiting
Study type
Observational
Enrollment
2000 (estimated)
First submitted
21 Jan 2021
Start date
1 Jun 2021
Primary completion date
31 Dec 2027
Lead sponsor
University Hospital Schleswig-Holstein
NCT number
NCT04724941

What you commit to

  • Study type: Observational
  • Planned participants: 2000
  • From 1 Jun 2021 to the primary completion date, 31 Dec 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Other significant neurologic diseases affecting the central nervous system (e.g. Multiple sclerosis)
  • other significant diseases e.g. orthopaedic diseases affecting quantitative motor assessment
  • in case of participation in the lumbal puncture substudy: contraindications for the performance of lumbal puncture (bleeding tendency, intake of anticoagulants)

Other

  • Presence of clinical PD at the time of study inclusion

Who the study is looking for

  • Age between 50 and 99

Age in the registry: 50 years to 99 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Department for Neurology, University of Kiel
Coordinator of this site? Confirm its status
KielGermanyRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.